Detalles de la búsqueda
1.
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies.
AIDS Res Ther
; 21(1): 17, 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38515183
2.
Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study.
Open Forum Infect Dis
; 11(1): ofad626, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38213637
3.
Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy-Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review.
Open Forum Infect Dis
; 9(4): ofac068, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35265729
Resultados
1 -
3
de 3
1
Próxima >
>>